In vivo immunopotentiating activity of thymopentin in aging humans: Modulation of IL-2 receptor expression
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 48 (2) , 140-149
- https://doi.org/10.1016/0090-1229(88)90078-5
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Encore OlduvaiScience, 2003
- Heterogeneity of immune responsiveness in healthy elderly subjectsClinical Immunology and Immunopathology, 1988
- In vivo immunopotentiating activity of thymopentin in aging humans: Increase of Il-2 productionClinical Immunology and Immunopathology, 1987
- Assessment of delayed-type hypersensitivity in man: A comparison of the “Multitest” and conventional intradermal injection of six antigensClinical Immunology and Immunopathology, 1985
- Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from patients with essential mixed cryoglobulinemiaClinical Immunology and Immunopathology, 1984
- Phase variation in the modulation of the human immune responseImmunology Today, 1983
- Comparative efficacy of various routes of administration of thymopentin (TP‐5) with consideration of degradative mechanismsInternational Journal of Peptide and Protein Research, 1983
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.Journal of Clinical Investigation, 1981
- A Synthetic Pentapeptide with Biological Activity Characteristic of the Thymic Hormone ThymopoietinScience, 1979